Group One Trading
BVS icon

Group One Trading’s Bioventus BVS Stock Holding History

Group One Trading’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-300
Closed -$2.75K – 7968
2025
Q1 		$2.75K Buy
300
+200
+200% +$2K ﹤0.01% 6890
2024
Q4 		$1.05K Sell
100
-200
-67% -$2.37K ﹤0.01% 6877
2024
Q3 		$3.58K Buy
+300
New +$2.59K ﹤0.01% 6005
2023
Q4 		– Sell
-100
Closed -$330 – 7427
2023
Q3 		$330 Sell
100
-400
-80% -$1.4K ﹤0.01% 7391
2023
Q2 		$1.45K Buy
+500
New +$960 ﹤0.01% 7177
2022
Q2 		– Sell
-4,900
Closed -$69K – 7845
2022
Q1 		$69K Sell
4,900
-10,200
-68% -$137K ﹤0.01% 5843
2021
Q4 		$219K Buy
+15,100
New +$215K ﹤0.01% 4991

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Group One Trading's BVS Position: Q1 2024 in Review

Group One Trading sold out of Bioventus (BVS) in Q1 2024, closing a stake of 10,385 shares — an estimated $50.8K sold.

Group One Trading first reported a position in BVS in Q4 2021 and held it in 4 quarters. The position peaked at $177K in Q4 2021. 84 funds tracked by Wall St. Rank hold BVS as of Q1 2024.

  • Group One Trading reported no remaining Bioventus position as of Q1 2024 after selling out during the quarter.
  • Group One Trading sold 10,385 Bioventus shares in Q1 2024, an estimated $50.8K.
  • Group One Trading first reported a position in Bioventus in Q4 2021 and held it in 4 quarters.
  • Group One Trading's Bioventus position peaked at $177K in Q4 2021.
  • 84 funds tracked by Wall St. Rank held Bioventus as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.